A reference standard with three deuteriums would in practice be impossible to distinguish from compounds with two to four deuteriums swapped, he says.
Another suggestion of Tung's -that the unaltered drug could be used as a reference against a deuterated version -also fails to allay the toxicologists' worries. "If all of a sudden deuterated paroxetine came onto the market and every vestige of the original went off the market and out of everyone's medicine cabinet, [Tung would be] right, " says Graham Jones, chief toxicologist for the Office of the Chief Medical Examiner in Edmonton, Canada, who maintains a widely used mass-spectrometry database for forensic toxicologists. But with deuterated and undeuterated versions of the drug on the market, there would be plenty of scope for error. "Using the drug as the internal standard would be complete forensic suicide, " says Kerrigan.
"It's not as simple as using a different drug, we' d have to develop specific methodology, " says Bruce Goldberger, director of toxicology at the University of Florida College of Medicine in Gainesville and editor of the Journal of Analytical Toxicology. This is a costly and lengthy process, he says. His lab spends up to $10,000 for each new methodology validation, which toxicologists must perform every time an aspect of their testing is changed.
Reference standards are bought from specialist companies, such as Cerilliant, in Round Rock, Texas, that provide certified materials. Cerilliant has a number of standards on its books and also synthesizes deuterated versions of known drugs to order. This, though, could lead to new problems if deuterated drugs are patented, and thus need to be made under licence. "We are concerned that the granting of these patents could severely restrict the production of reference materials, " says Mitzi Rettinger, Cerilliant's vice-president of sales and marketing.
Kerrigan hopes to alert the US Food and Drug Administration to her concerns, and let her colleagues internationally know of the situation through a letter in the Journal of Analytical Toxicology. She thinks it will be possible to cope with small numbers of such drugs. "If it is forced on us, we'll adapt, " says Goldberger. "I'm all for forward-looking medicine, " Kerrigan says, "but the benefits have to outweigh this huge disadvantage. "
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Forensic labs warn of deuterated drug threat It's that damn deuterium again, Horatio.
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